Viper ULTRA Tromboliz Kateteri

Bir ultra için özel infüzyon kateteri doğrudan trombolitik dağıtım, aşağıdakileri içerir çoklu delik ilaçları geniş pıhtı segmentlerine eşit olarak dağıtmak için tasarım.

Bu Viper® Ultrasonic Pharmacomechanical Thrombolysis System bir minimal invaziv için tasarlanmış cihaz dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin ve increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications ve preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

Ürün Özellikleri

Şartname Detay / Değer
Ürün Adı Viper ULTRA Tromboliz Kateteri
Kullanım Amacı Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Kateter Tasarımı Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Malzeme Pebax/Polyamide shaft, potentially braided or reinforced
Dış Çap (F) ~4–6F (depending on infusion lumen capacity)
Çalışma Uzunluğu ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Kılavuz Tel Uyumluluğu Typically 0.014” or 0.018”
Sterilite Steril, Tek Kullanımlık
Raf Ömrü 15-25 °C'de kapalı ambalajda saklandığında ~2-3 yıl
Klinik Endikasyonlar Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Kontrendikasyonlar Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Sipariş ve Boyut Matrisi

Dış Çap (F) Çalışma Uzunluğu (cm) Infusion Segment (cm) Ürün Kodu Notlar
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment